Back to Search
Start Over
Pharmacokinetic bioequivalence, safety and acceptability of Ornibel®, a new polymer composition contraceptive vaginal ring (etonogestrel/ethinylestradiol 11.00/3.474 mg) compared with Nuvaring® (etonogestrel/ethinylestradiol 11.7/2.7 mg)
- Source :
- The European Journal of Contraception & Reproductive Health Care. 22:429-438
- Publication Year :
- 2017
- Publisher :
- Informa UK Limited, 2017.
-
Abstract
- Objective: To show the clinical development of Ornibel® (ExeltisHealthcare, Spain) a contraceptive vaginal ring manufactured with a new polymer composition and containing etonogestrel/ethin...
- Subjects :
- 030219 obstetrics & reproductive medicine
Polymer composition
Burst effect
business.industry
User satisfaction
Obstetrics and Gynecology
Pharmacology
Bioequivalence
Vaginal ring
03 medical and health sciences
0302 clinical medicine
Reproductive Medicine
Pharmacokinetics
030220 oncology & carcinogenesis
Ethinylestradiol
medicine
Pharmacology (medical)
business
Etonogestrel
medicine.drug
Subjects
Details
- ISSN :
- 14730782 and 13625187
- Volume :
- 22
- Database :
- OpenAIRE
- Journal :
- The European Journal of Contraception & Reproductive Health Care
- Accession number :
- edsair.doi...........7c4d010d2b7b7fdfb083f87eb436a1a7
- Full Text :
- https://doi.org/10.1080/13625187.2017.1413179